Drug Trial Radar · NCT05816382
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Apr 5, 2023
Primary completion
Feb 28, 2028
Study completion Feb 28, 2028
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Apr 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-861.
Conditions
- Narcolepsy Type 1
Interventions
TAK-861Drug
TAK-861 tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With at Least One or More Treatment-emergent Adverse Events (TEAEs)Time frame: From signing the informed consent form up to follow-up of 4 weeks after the last dose (Up to approximately 5 years)
Locations
52 sites in 12 countries. Site status is shown where the registry gives one.
Sleep Disorders Center of Alabama
Birmingham, Alabama · Recruiting
Stanford Center for Sleep Sciences and Medicine
Redwood City, California · Recruiting
SDS Clinical Trials, Inc.
Santa Ana, California · Recruiting
Delta Waves LLC - Hunt - PPDS
Colorado Springs, Colorado · Recruiting
Florida Pediatric Research Institute
Orlando, Florida · Recruiting
Neurotrials Research
Atlanta, Georgia · Recruiting
Georgia Neuro Center
Gainesville, Georgia · Recruiting
Neurocare Inc
Newton, Massachusetts · Recruiting
Henry Ford Medical Center - Columbus
Novi, Michigan · Recruiting
Research Carolina Elite
Denver, North Carolina · Recruiting
ARSM Research, LLC
Huntersville, North Carolina · Recruiting
CTI Research Center
Cincinnati, Ohio · Recruiting
Intrepid Research
Cincinnati, Ohio · Recruiting
The Cleveland Clinic Foundation
Cleveland, Ohio · Recruiting
Ohio Sleep Medicine Institute
Dublin, Ohio · Recruiting
Medical University of South Carolina - PPDS
Charleston, South Carolina · Recruiting
Bogan Sleep Consultants, LLC
Columbia, South Carolina · Recruiting
Sleep Therapy and Research Center
San Antonio, Texas · Recruiting
Children's Specialty Group
Norfolk, Virginia · Recruiting
Woolcock Institute of Medical Research
Glebe, New South Wales, Australia · Recruiting
Terveystalo Helsinki Sleep Clinic
Helsinki, Uusimaa, Finland · Recruiting
Hopital de la Pitie Salpetriere
Paris, France · Recruiting
Hopital Pierre-Paul Riquet
Toulouse, Haute-Garonne, France · Recruiting
CHU Gui De Chauliac
Montpellier, Herault, France · Recruiting
CHU de Grenoble
La Tronche, Isere, France · Recruiting
Charite - Universitatsmedizin Berlin
Berlin, Germany · Recruiting
Klinische Forschung Hamburg
Hamburg, Germany · Recruiting
Universitaet Regensburg am Bezirksklinikum
Regensburg, Bavaria, Germany · Recruiting
Somni Bene Institut fur Medizinische Forschung und Schlafmedizin Schwerin GmbH
Schwerin, Mecklenburg-Vorpommern, Germany · Recruiting
Ospedale Bellaria
Bellaria, Italy · Recruiting
Fondazione PTV Policlinico Tor Vergata
Rome, Lazio, Italy · Recruiting
Istituto Neurologico Mediterraneo Neuromed
Pozzilli, Molise, Italy · Recruiting
Aichi Medical University Hospital
Nagakute, Japan · Recruiting
Kurume University Hospital
Kurume-Shi, Hukuoka, Japan · Recruiting
Howakai Kuwamizu Hospital
Kumamoto, Kumamoto, Japan · Recruiting
YOU ARIYOSHI Sleep Clinic
Nagasaki, Nagasaki, Japan · Recruiting
Gokeikai Osaka Kaisei Hospital
Osaka, Osaka, Japan · Recruiting
Koishikawa Tokyo Hospital
Bunkyo-Ku, Tokyo, Japan · Recruiting
Kempenhaeghe - PPDS
Heeze, North Brabant, Netherlands · Recruiting
Slaap-Waakcentrum SEIN Heemstede
Heemstede, North Holland, Netherlands · Recruiting
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.